Mochida Pharmaceutical (4534) · RiskFirst stated

Legal, Regulatory and Geopolitical Risks Associated with Overseas Expansion

First written in FY2026. . Latest entry: FY2026.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Risks Relating to Laws and Regulations and Political and Economic Conditions in Overseas MarketsA theme 446 companies write about · 452 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 47 of 94 companies on the "Worse" side.

7 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 452 threads.

Full recordFilings, disclosures and news, newest first

FY2026First statedAnnual report
「When conducting business activities overseas, the Group may be affected in its operating results and financial condition if risks such as changes in the relevant country's laws and regulations, changes in economic conditions, geopolitical risks including political instability, and uncertainty in the business environment materialise, resulting in stagnation of business activities or delays in or cancellation of business expansion.」
With the expansion of its overseas operations, the Company has for the first time identified legal and regulatory risks, economic conditions, political instability and uncertainty in the business environment as standalone business and other risks.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Mochida Pharmaceutical yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.